How Nitches Inc, Wholy Owned Subsidiary InTheZone Labs Inspired a Team of Scientists, Biochemists and Researchers to Formulate a Breakthrough Next-Level Nootropic
Rhea-AI Summary
Nitches Inc (OTC PINK:NICH) has announced through its subsidiary InTheZone Labs the development of a breakthrough nootropic supplement. The product combines ingredients like L-theanine, alpha-GPC, lion's mane mushrooms, and phosphatidylserine to enhance cognitive function.
A phase 1 study with 33 participants, including venture capitalists, students, veterans, and professionals, showed that 93% reported improvements in memory, focus, and productivity. The study results were analyzed using artificial intelligence to determine the specific improvement percentage.
The company has launched two products - InTheZone Youth and InTheZone Focused Extreme - available on Amazon and TikTok Shop. With the global nootropic market projected to exceed $10 billion, the company aims to capitalize on the growing demand for natural cognitive enhancers.
Positive
- 93% of study participants reported improvements in memory, focus, and productivity
- Products already launched and available on major platforms (Amazon, TikTok Shop)
- Targeting $10 billion global nootropic market opportunity
Negative
- initial study size of only 33 participants
- Products not yet FDA evaluated or approved
- Faces competition in saturated nootropic market
MIAMI, FL / ACCESSWIRE / January 3, 2025 / Nitches Inc (OTC PINK:NICH) How Nitches Inc, wholly owned subsidiary InTheZone Labs inspired a team of scientists, biochemists and researchers to Formulate a Breakthrough Next-Level Nootropic that's Empowering Driven Individuals to Dominate Deadlines and Demanding Tasks After Discovering This Blend, It Was Shared With 33 Hardworking Individuals From All Walks of Life
InTheZone has officially unveiled a nootropic blend that could redefine how entrepreneurs, students, and even former NFL players power through grueling days. Spearheaded by a biochemist and neuroscientist and inspired by the relentless schedule of a seasoned entrepreneur, this premium blend merges high-impact ingredients like L-theanine, alpha-GPC, lion's mane mushrooms, and phosphatidylserine-each scientifically linked to boosted cognition and calm concentration.
With global nootropic markets projected to exceed
Key Takeaways from the Phase 1 Study and Results:
• Immediate Focus, Zero Crash: A consistent theme among participants was calm, laser-focused attention without caffeine-induced jitters. Former NFL pros praised the supplement for its ability to sustain mental clarity even on demanding schedules.
• Customizable Dosages: Bigger-bodied testers - over 6'2" and 200 lbs - experienced optimal benefits at three capsules, with
• Real Science, Real Results: Leveraging proven nootropic ingredients, InTheZone users discovered a sustainable alternative to prescription stimulants. Notably, testers with high-stress roles - like neurosurgeons - reported newfound clarity and fewer side effects.
• Broad Lifestyle Integration: Students tackling finals credited InTheZone for sharper concentration under deadline pressure. Parents reported smoother multitasking, citing decreased irritability.
"This isn't about a quick thrill. It's about amplifying the best in you - sustainably, consistently, and without compromise," stated one of the biochemists behind the formula.
Availability
Both InTheZone Youth and InTheZone Focused Extreme are now available on Amazon and the TikTok Shop.
Market Outlook
The surge in demand for natural cognitive enhancers creates a ripe environment for InTheZone. With both InTheZone Youth and InTheZone Focused Extreme available on Amazon and TikTok Shop - and a special GovX discount for veterans and first responders-company insiders project swift market penetration. As more professionals pivot to cleaner, science-backed strategies for mental performance, early indicators suggest InTheZone could emerge as a strong contender in the evolving nootropic space.
FDA Disclaimer:
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult with your healthcare provider before starting any new dietary supplement, especially if you are pregnant, nursing, taking medication, or have a medical condition.
For additional updates, shareholders are encouraged to follow our progress at www.inthezonelabs.com
Forward-Looking Statements:
This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on current expectations, estimates, and projections about Nitches Corp's industry, management's beliefs, and certain assumptions made by management. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual results may differ materially from what is expressed or forecasted in such forward-looking statements. Except as required by law, Nitches Corp undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise.
View the original press release on accesswire.com
FAQ
What were the results of InTheZone Labs' Phase 1 nootropic study for NICH stock?
Where can investors buy InTheZone products from Nitches Inc (NICH)?
What key ingredients are in NICH's InTheZone nootropic formula?
What is the market potential for NICH's nootropic products?
